Abstract:The reaction of an organometallic reagent with a diastereomerically pure sulfinate ester of menthol1 continues to be the method most often employed for the preparation of optically active sulfoxides, despite recent advances in the asymmetric oxidation of sulfides.2 These sulfoxides have proven to be valuable intermediates for asymmetric synthesis.3 The requisite sulfinate esters are generally
“…The hydroxyl group of chiral epoxy alcohol 10 was substituted by thioacetate in a one-pot reaction using triphenylphosphine (PPh 3 ), diisopropyl azodicarboxylate (DIAD), and thioacetic acid in tetrahydrofuran to give 11 in 96% yield (Scheme ) using a modified Mitsunobu procedure, developed by Volante . Treatment of 11 with sodium hydroxide (0.5 M) using standard conditions for the Payne rearrangement 20 failed to produce 12 , likely due to extensive polymerization of the terminal thiirane in the alkaline media .…”
The synthesis of [4,5-bis(hydroxymethyl)-1,3-oxathiolan-2-yl]nucleosides is described. 2,3-Epoxy alcohol 10 was converted in one pot into thioacetate 11. Treatment of 11 under mild alkaline conditions gave thiirane 12 with inversion of configuration at C-2. We also found that thioacetate 11 rearranges into thiirane 14 under mild acidic conditions. This rearrangement reaction was shown by independent synthesis to proceed with net retention of configuration at C-2. We have proposed a tentative mechanism which may explain the results obtained. Opening of thiiranes 12 and 14 followed by deprotection gave (2R,3R)-2-thiothreitol (23) and (2S,3R)-2-thioerythritol (25), respectively. Regioselective silylation of the primary hydroxyl groups of 23 followed by treatment with trimethyl orthoformate gave 2-methoxy-1,3-oxathiolanes 26 and 27. Condensation with silylated bases followed by deprotection and separation of the anomers gave the oxathiolanylnucleosides. Compounds 29-31, 34, and 35 were found to be inactive when tested for inhibition of HIV-1 activity in vitro.
“…The hydroxyl group of chiral epoxy alcohol 10 was substituted by thioacetate in a one-pot reaction using triphenylphosphine (PPh 3 ), diisopropyl azodicarboxylate (DIAD), and thioacetic acid in tetrahydrofuran to give 11 in 96% yield (Scheme ) using a modified Mitsunobu procedure, developed by Volante . Treatment of 11 with sodium hydroxide (0.5 M) using standard conditions for the Payne rearrangement 20 failed to produce 12 , likely due to extensive polymerization of the terminal thiirane in the alkaline media .…”
The synthesis of [4,5-bis(hydroxymethyl)-1,3-oxathiolan-2-yl]nucleosides is described. 2,3-Epoxy alcohol 10 was converted in one pot into thioacetate 11. Treatment of 11 under mild alkaline conditions gave thiirane 12 with inversion of configuration at C-2. We also found that thioacetate 11 rearranges into thiirane 14 under mild acidic conditions. This rearrangement reaction was shown by independent synthesis to proceed with net retention of configuration at C-2. We have proposed a tentative mechanism which may explain the results obtained. Opening of thiiranes 12 and 14 followed by deprotection gave (2R,3R)-2-thiothreitol (23) and (2S,3R)-2-thioerythritol (25), respectively. Regioselective silylation of the primary hydroxyl groups of 23 followed by treatment with trimethyl orthoformate gave 2-methoxy-1,3-oxathiolanes 26 and 27. Condensation with silylated bases followed by deprotection and separation of the anomers gave the oxathiolanylnucleosides. Compounds 29-31, 34, and 35 were found to be inactive when tested for inhibition of HIV-1 activity in vitro.
“…The tedious chromatographic separation required to remove the unwanted p -nitrobenzoate 6 from 5 prompted a search for an improved synthesis of 8 , and the epoxide 9 , obtained enantiopure after a single crystallization following Sharpless asymmetric epoxidation of the mono p -bromobenzyl ether of cis -buten-1,4-diol, provided the starting point for a new approach as shown in Scheme . Exposure of 9 to methylmagnesium bromide and cuprous iodide afforded a 3:1 mixture of 1,3- and 1,2-diols, from which the undesired 1,2-diol was easily removed by oxidative cleavage with sodium periodate.…”
Rhizoxin D (2) was synthesized from four subunits, A, B, C, and D representing C3-C9, C10-C13, C14-C19, and C20-C27, respectively. Subunit A was prepared by cyclization of iodo acetal 21, which set the configuration at C5 of 2 through a stereoselective addition of the radical derived from dehalogenation of 21 at the beta carbon of the (Z)-alpha,beta-unsaturated ester. Aldehyde 29 was obtained from phenylthioacetal 24 and condensed with phosphorane 30, representing subunit B, in a Wittig reaction that gave the (E,E)-dienoate 31. This ester was converted to aldehyde 33 in preparation for coupling with subunit C. The latter in the form of methyl ketone 55 was obtained in six steps from propargyl alcohol. An aldol reaction of 33 with the enolate of 55 prepared with (+)-DIPCl gave the desired beta-hydroxy ketone 56 bearing a (13S)-configuration in a 17-20:1 ratio with its (13R)-diastereomer. After reduction to anti diol 57 and selective protection as TIPS ether 58, the C15 hydroxyl was esterified to give phosphonate 59. An intramolecular Wadsworth-Emmons reaction of aldehyde 62, derived from delta-lactone 60, furnished macrolactone 63, which was coupled in a Stille reaction with stannane 68 to give 2 after cleavage of the TIPS ether.
“…In the course of a synthesis of oxetanocins A and G ( 1a,b ), the known epoxide (−)- 4 12 was made from the known monoprotected 2-butene-1,4-diol 3 (itself prepared by simple alkylation of butenediol in 88% yield) in 96% ee via a Sharpless epoxidation (Scheme 1). Addition of vinylmagnesium bromide proceeded highly stereoselectively to give primarily the 1,3-diol 5 , with a small inseparable impurity (presumably the 1,2-diol).…”
We report a novel route to isonucleosides of the
‘methylene-expanded' oxetanocin class, in both the
d- and l-enantiomeric forms, e.g., compounds
l-(+)-2a, d-(−)-2a,
and l-(−)-2b, beginning with the
simple, known mono-p-bromobenzyl ether 3 of the
very inexpensive 2-butene-1,4-diol. Sharpless
asymmetric epoxidation of 3 gave either (−) or
(+)-4 depending on the chirality of the
tartrate
used. The p-bromobenzyl ether was used since the
epoxide product is crystalline and can be
recrystallized to high optical purity. Opening of the epoxide with
vinylmagnesium bromide gave
the 1,3-diol 5, the primary alcohol of which was protected
as the silyl ether 6. Treatment of 6
with
iodonium bis(sym-collidine) perchlorate afforded the desired
5-(iodomethyl)tetrahydrofuran-3-ol 8
with loss of the bromobenzyl cation in the key step in the synthetic
scheme. This iodide 8 was
then converted into the bis(silyloxy)-protected alcohol 15
by acetylation to give the acetate 10,
displacement of iodide with acetate, hydrolysis, and selective
protection of the primary alcohols.
The alcohol 6 could also be converted into
15 via initial acetylation and then iodocyclization to
give
10. The diol 5 could also be converted into
15 by a similar route involving bis-acetylation
and
iodocyclization followed by functional group transformations. The
tosylate of 15 was displaced
with the anion of adenine or thymidine to give, after final
desilylation, the desired isonucleosidesthe
d-adenosine analogue (−)-2a and the
l-adenosine and thymidine analogues (+)-2a and
(−)-2b. All
of the stereochemistry of the final products is derived from the first
step of the synthesis, namely,
the Sharpless asymmetric epoxidation of 3. The
biological activity of the new compounds
l-(+)-2a
and l-(−)-2b against HIV was determined in the
anti-HIV drug-testing system of the National
Cancer Institute. The adenosine analogue
l-(+)-2a was inactive in this screen, while
the thymidine
analogue l-(−)-2b showed moderate anti-HIV
activity (IC50 > 2 × 10-4 M,
EC50 = 8 × 10-7 M,
TI50
> 250).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.